Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CFD | P00746 | 1/20 | 0.45 |
| ▸ | RXRB | P28702 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | GFER | P55789 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | MCL1 | Q07820 | 4/20 | 0.41 |
| ▸ | RXRA | P19793 | 3/20 | 0.40 |
| ▸ | NR1H2 | P55055 | 2/20 | 0.40 |
| ▸ | NR1H3 | Q13133 | 2/20 | 0.40 |
| ▸ | ACMSD | Q8TDX5 | 3/20 | 0.40 |
| ▸ | HNF4A | P41235 | 2/20 | 0.40 |
| ▸ | CA12 | O43570 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.40 |
| ▸ | DHFR | P00374 | 1/20 | 0.40 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27389488 | 0.85 | ALDH1A1 (0.37) | KMT2AALDH1A1RXRANR1H2NR1H3 | |
| SCHEMBL828860 | 0.85 | ALDH1A1 (0.37) | KMT2AALDH1A1RXRANR1H2NR1H3 | |
| SCHEMBL828474 | 0.85 | ALDH1A1 (0.37) | KMT2AALDH1A1RXRANR1H2NR1H3 | |
| SCHEMBL28401369 | 0.85 | ALDH1A1 (0.37) | KMT2AALDH1A1RXRANR1H2NR1H3 | |
| SCHEMBL17713226 | 0.83 | KDM4E (0.50) | KDM4EALDH1A1RXRANR1H2NR1H3 | |
| SCHEMBL30638610 | 0.83 | KDM4E (0.50) | KDM4EALDH1A1RXRANR1H2NR1H3 | |
| SCHEMBL9618204 | 0.82 | ALDH1A1 (0.38) | KDM4EKMT2AALDH1A1RXRANR1H2 | |
| SCHEMBL436207 | 0.81 | ALDH1A1 (0.51) | KDM4EKMT2AALDH1A1MCL1NR1H2 | |
| SCHEMBL15920614 | 0.81 | KDM4E (0.47) | KDM4E | |
| SCHEMBL20928676 | 0.81 | ALDH1A1 (0.38) | RXRBKDM4EALDH1A1RXRANR1H2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0311374-B1 | DICYLCOHEXYL-3,4,3'4'-TETRA-CARBOXYLIC ACID OR DIANHYDRIDE THEREOF AND POLYAMIDE-ACID AND POLYMIDE OBTAINED THEREFROM | Hitachi Chemical Co., Ltd. (JP) | 1992-09-09 | — | — | EP | claimed |
| US-4958001-A | LIQUID CRYSTAL DISPLAY DEVICE | HITACHI CHEMICAL COMPANY, LTD. (JP) | 1990-09-18 | — | — | US | claimed |
| EP-0311374-A2 | Dicylcohexyl-3,4,3'4'-tetra-carboxylic acid or dianhydride thereof and polyamide-acid and polymide obtained therefrom | Hitachi Chemical Co., Ltd. (JP) | 1989-04-12 | — | — | EP | claimed |
| JP-7215912-A | — | — | None | — | — | JP | disclosed |
| CN-110818551-B | Synthetic method of 3,3',4,4' -biphenyltetracarboxylic acid | 常州市阳光药业有限公司 | 2022-06-24 | — | — | CN | disclosed |
| CN-113667104-A | Hyperbranched polyester and preparation method thereof | 扬州帅帅高分子科技有限公司 | 2021-11-19 | — | — | CN | disclosed |
| CN-110818551-A | Synthetic method of 3,3',4,4' -biphenyltetracarboxylic acid | 常州市阳光药业有限公司 | 2020-02-21 | — | — | CN | disclosed |
| US-9469621-B2 | Method for producing multisubstituted biphenyl compound and solid catalyst to be used therein | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) | 2016-10-18 | — | — | US | disclosed |
| US-20150274689-A1 | METHOD FOR PRODUCING MULTISUBSTITUTED BIPHENYL COMPOUND AND SOLID CATALYST TO BE USED THEREIN | UBE CORPORATION (JP) | 2015-10-01 | — | — | US | disclosed |
| US-6914154-B2 | Process for production of biphenyltetracarboxylic acid tetraesters | UBE INDUSTRIES, LTD. (JP) | 2005-07-05 | — | — | US | disclosed |
| US-20040039222-A1 | Process for production of biphenyltetracarboxylic acid tetraesters | UBE INDUSTRIES, LTD. (JP) | 2004-02-26 | — | — | US | disclosed |
| JP-H07215912-A | NEW DICYCLOHEXYL-3,4,3',4'-TETRACARBOXYLIC ACID AND ITS PRODUCTION | HITACHI CHEM CO LTD | 1995-08-15 | — | — | JP | disclosed |
| US-5216173-A | Curing agents for epoxy resins; polyimides | HENKEL RESEARCH CORPORATION (US) | 1993-06-01 | — | — | US | disclosed |
| EP-0311374-B1 | DICYLCOHEXYL-3,4,3'4'-TETRA-CARBOXYLIC ACID OR DIANHYDRIDE THEREOF AND POLYAMIDE-ACID AND POLYMIDE OBTAINED THEREFROM | Hitachi Chemical Co., Ltd. (JP) | 1992-09-09 | — | — | EP | disclosed |
| WO-1991001307-A2 | N-CYANOIMIDES AND PROCESS FOR THEIR PREPARATION AND USES THEREOF | HENKEL RESEARCH CORPORATION (US) | 1991-02-07 | — | — | WO | disclosed |
| US-4958001-A | LIQUID CRYSTAL DISPLAY DEVICE | HITACHI CHEMICAL COMPANY, LTD. (JP) | 1990-09-18 | — | — | US | disclosed |
| EP-0311374-A2 | Dicylcohexyl-3,4,3'4'-tetra-carboxylic acid or dianhydride thereof and polyamide-acid and polymide obtained therefrom | Hitachi Chemical Co., Ltd. (JP) | 1989-04-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040039222-A1 | Process for production of biphenyltetracarboxylic acid tetraesters | PCCA, DDT, DECR2 | CFD 1275/4885RXRB 1214/4885KDM4E 3277/4885 |
| US-20150274689-A1 | METHOD FOR PRODUCING MULTISUBSTITUTED BIPHENYL COMPOUND AND SOLID CATALYST TO BE USED THEREIN | DDT, CYP1A1, CYP1B1 | CFD 4502/4885RXRB 1369/4885KDM4E 357/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.